| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Apoptosis | 50 | 2025 | 1069 | 9.310 |
Why?
|
| Caspases | 32 | 2024 | 174 | 8.280 |
Why?
|
| Drosophila Proteins | 44 | 2022 | 691 | 7.230 |
Why?
|
| Drosophila melanogaster | 26 | 2025 | 493 | 4.970 |
Why?
|
| Drosophila | 32 | 2023 | 431 | 4.690 |
Why?
|
| Cell Proliferation | 24 | 2025 | 979 | 4.680 |
Why?
|
| Reactive Oxygen Species | 8 | 2022 | 223 | 2.390 |
Why?
|
| Regeneration | 6 | 2019 | 93 | 1.970 |
Why?
|
| Neoplasms | 12 | 2025 | 1351 | 1.870 |
Why?
|
| Eye | 12 | 2016 | 54 | 1.840 |
Why?
|
| Animals | 67 | 2025 | 20501 | 1.710 |
Why?
|
| Signal Transduction | 21 | 2025 | 3014 | 1.700 |
Why?
|
| MAP Kinase Kinase 4 | 5 | 2020 | 46 | 1.680 |
Why?
|
| Ubiquitination | 7 | 2017 | 111 | 1.470 |
Why?
|
| Cell Death | 6 | 2025 | 284 | 1.460 |
Why?
|
| Enterocytes | 2 | 2022 | 24 | 1.430 |
Why?
|
| Receptors, Notch | 7 | 2013 | 101 | 1.290 |
Why?
|
| Hedgehog Proteins | 3 | 2023 | 111 | 1.190 |
Why?
|
| Protein Precursors | 7 | 2025 | 82 | 1.030 |
Why?
|
| Autophagy | 5 | 2021 | 225 | 1.020 |
Why?
|
| MAP Kinase Signaling System | 5 | 2017 | 226 | 1.010 |
Why?
|
| Mutation | 19 | 2021 | 2597 | 0.970 |
Why?
|
| Carcinogenesis | 2 | 2019 | 129 | 0.940 |
Why?
|
| Inhibitor of Apoptosis Proteins | 10 | 2014 | 39 | 0.910 |
Why?
|
| Macrophages | 4 | 2020 | 1033 | 0.890 |
Why?
|
| Homeostasis | 5 | 2025 | 369 | 0.880 |
Why?
|
| Necrosis | 1 | 2024 | 141 | 0.860 |
Why?
|
| ErbB Receptors | 4 | 2014 | 114 | 0.830 |
Why?
|
| Gene Expression Regulation | 3 | 2021 | 1596 | 0.790 |
Why?
|
| Caspase 3 | 2 | 2014 | 108 | 0.720 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 5 | 2013 | 57 | 0.690 |
Why?
|
| Basement Membrane | 1 | 2020 | 25 | 0.670 |
Why?
|
| Cell Differentiation | 8 | 2012 | 1337 | 0.670 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2020 | 29 | 0.670 |
Why?
|
| Macrophage Activation | 1 | 2020 | 119 | 0.650 |
Why?
|
| Myosins | 2 | 2018 | 112 | 0.640 |
Why?
|
| Enkephalins | 4 | 2025 | 20 | 0.640 |
Why?
|
| Proteolysis | 3 | 2022 | 145 | 0.630 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 157 | 0.620 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 2 | 2010 | 8 | 0.620 |
Why?
|
| Intestinal Mucosa | 1 | 2021 | 245 | 0.600 |
Why?
|
| Neoplasms, Experimental | 1 | 2018 | 77 | 0.570 |
Why?
|
| Gene Expression Regulation, Developmental | 7 | 2014 | 635 | 0.560 |
Why?
|
| Epithelial Cells | 2 | 2017 | 385 | 0.560 |
Why?
|
| Carrier Proteins | 4 | 2009 | 702 | 0.550 |
Why?
|
| Neuropeptides | 7 | 2009 | 82 | 0.550 |
Why?
|
| Models, Biological | 8 | 2017 | 1174 | 0.550 |
Why?
|
| Trans-Activators | 2 | 2012 | 312 | 0.540 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2017 | 55 | 0.540 |
Why?
|
| Myotonic Dystrophy | 1 | 2017 | 13 | 0.540 |
Why?
|
| DNA Repeat Expansion | 1 | 2017 | 58 | 0.530 |
Why?
|
| Cell Survival | 9 | 2023 | 566 | 0.530 |
Why?
|
| Biomarkers | 7 | 2025 | 1391 | 0.490 |
Why?
|
| Cell Membrane | 1 | 2018 | 492 | 0.480 |
Why?
|
| Larva | 5 | 2020 | 139 | 0.480 |
Why?
|
| STAT Transcription Factors | 2 | 2013 | 18 | 0.470 |
Why?
|
| Mammals | 4 | 2022 | 216 | 0.460 |
Why?
|
| Caspase 9 | 2 | 2017 | 22 | 0.450 |
Why?
|
| Photoreceptor Cells | 1 | 2014 | 20 | 0.440 |
Why?
|
| Humans | 39 | 2025 | 63001 | 0.440 |
Why?
|
| Receptors, Invertebrate Peptide | 1 | 2014 | 3 | 0.440 |
Why?
|
| Oxidoreductases, N-Demethylating | 2 | 2013 | 4 | 0.430 |
Why?
|
| Neurotensin | 3 | 2020 | 9 | 0.430 |
Why?
|
| Cell Cycle | 3 | 2010 | 384 | 0.430 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2014 | 19 | 0.430 |
Why?
|
| RNA | 1 | 2017 | 423 | 0.420 |
Why?
|
| Neurons | 3 | 2017 | 918 | 0.410 |
Why?
|
| Janus Kinases | 1 | 2013 | 17 | 0.410 |
Why?
|
| Endosomes | 3 | 2009 | 178 | 0.400 |
Why?
|
| Molecular Biology | 1 | 2014 | 66 | 0.400 |
Why?
|
| Ubiquitin-Activating Enzymes | 2 | 2011 | 7 | 0.370 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2013 | 204 | 0.370 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2017 | 303 | 0.370 |
Why?
|
| Cardiovascular Diseases | 4 | 2022 | 832 | 0.360 |
Why?
|
| Nuclear Proteins | 3 | 2012 | 774 | 0.350 |
Why?
|
| Mosaicism | 2 | 2012 | 30 | 0.350 |
Why?
|
| Phenotype | 7 | 2011 | 1192 | 0.340 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2010 | 81 | 0.320 |
Why?
|
| Lysine | 1 | 2010 | 82 | 0.320 |
Why?
|
| Imaginal Discs | 3 | 2020 | 3 | 0.310 |
Why?
|
| Disease Models, Animal | 4 | 2020 | 2167 | 0.310 |
Why?
|
| Stem Cells | 1 | 2010 | 256 | 0.300 |
Why?
|
| Histones | 3 | 2013 | 479 | 0.290 |
Why?
|
| Neoplasm Proteins | 2 | 2015 | 279 | 0.290 |
Why?
|
| Genes, Insect | 5 | 2011 | 90 | 0.290 |
Why?
|
| Fasting | 3 | 2017 | 51 | 0.290 |
Why?
|
| Photoreceptor Cells, Invertebrate | 3 | 2017 | 36 | 0.290 |
Why?
|
| Ubiquitin | 5 | 2010 | 97 | 0.290 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2021 | 185 | 0.290 |
Why?
|
| Protein Transport | 4 | 2013 | 400 | 0.280 |
Why?
|
| Vesicular Transport Proteins | 1 | 2009 | 113 | 0.280 |
Why?
|
| Multiprotein Complexes | 1 | 2009 | 153 | 0.280 |
Why?
|
| RNA Transport | 1 | 2006 | 31 | 0.250 |
Why?
|
| I-kappa B Kinase | 1 | 2006 | 50 | 0.250 |
Why?
|
| Human Growth Hormone | 2 | 2017 | 19 | 0.250 |
Why?
|
| Cytoskeleton | 1 | 2006 | 137 | 0.240 |
Why?
|
| Alleles | 5 | 2007 | 446 | 0.240 |
Why?
|
| DNA-Binding Proteins | 3 | 2013 | 1177 | 0.240 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2005 | 51 | 0.240 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2006 | 148 | 0.240 |
Why?
|
| Transcription Factors | 5 | 2013 | 1502 | 0.240 |
Why?
|
| Membrane Proteins | 4 | 2018 | 892 | 0.230 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 4 | 2022 | 140 | 0.230 |
Why?
|
| Molecular Sequence Data | 5 | 2009 | 1980 | 0.220 |
Why?
|
| Models, Genetic | 3 | 2014 | 258 | 0.220 |
Why?
|
| Protein Binding | 4 | 2017 | 1595 | 0.220 |
Why?
|
| Homeodomain Proteins | 1 | 2005 | 266 | 0.210 |
Why?
|
| Growth | 1 | 2003 | 22 | 0.210 |
Why?
|
| Wings, Animal | 4 | 2016 | 20 | 0.210 |
Why?
|
| Acute Kidney Injury | 1 | 2025 | 146 | 0.200 |
Why?
|
| Heart Failure | 3 | 2019 | 912 | 0.190 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2003 | 217 | 0.190 |
Why?
|
| Feedback | 1 | 2022 | 93 | 0.190 |
Why?
|
| Catecholamines | 1 | 2022 | 29 | 0.190 |
Why?
|
| Retina | 2 | 2017 | 124 | 0.190 |
Why?
|
| ras Proteins | 2 | 2018 | 77 | 0.190 |
Why?
|
| Acute Coronary Syndrome | 1 | 2025 | 251 | 0.180 |
Why?
|
| Neuroglia | 1 | 2002 | 78 | 0.180 |
Why?
|
| Amino Acid Sequence | 4 | 2009 | 1583 | 0.180 |
Why?
|
| Actins | 1 | 2022 | 259 | 0.180 |
Why?
|
| Nitric Oxide | 1 | 2022 | 172 | 0.170 |
Why?
|
| Small Molecule Libraries | 1 | 2021 | 58 | 0.170 |
Why?
|
| Fats, Unsaturated | 1 | 2020 | 2 | 0.170 |
Why?
|
| Recombinant Proteins | 1 | 2022 | 695 | 0.170 |
Why?
|
| Drug Discovery | 1 | 2021 | 95 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2022 | 694 | 0.170 |
Why?
|
| Protein Structure, Tertiary | 4 | 2006 | 670 | 0.160 |
Why?
|
| Selenoprotein P | 1 | 2019 | 1 | 0.160 |
Why?
|
| Glomerular Filtration Rate | 2 | 2019 | 113 | 0.160 |
Why?
|
| Deficiency Diseases | 1 | 2019 | 13 | 0.160 |
Why?
|
| Dietary Fats | 1 | 2020 | 175 | 0.160 |
Why?
|
| Mice | 5 | 2024 | 10751 | 0.150 |
Why?
|
| Triglycerides | 1 | 2020 | 244 | 0.150 |
Why?
|
| Renal Insufficiency | 1 | 2019 | 66 | 0.150 |
Why?
|
| Male | 13 | 2025 | 29706 | 0.150 |
Why?
|
| Caenorhabditis elegans | 1 | 2025 | 672 | 0.150 |
Why?
|
| Sequence Alignment | 2 | 2009 | 300 | 0.140 |
Why?
|
| Immunohistochemistry | 2 | 2012 | 886 | 0.140 |
Why?
|
| Female | 15 | 2025 | 32654 | 0.140 |
Why?
|
| Pentamidine | 1 | 2017 | 2 | 0.140 |
Why?
|
| eIF-2 Kinase | 1 | 2017 | 9 | 0.140 |
Why?
|
| Carotid Intima-Media Thickness | 1 | 2017 | 13 | 0.140 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2017 | 17 | 0.140 |
Why?
|
| Muscular Atrophy | 1 | 2017 | 26 | 0.130 |
Why?
|
| Caspase 2 | 1 | 2017 | 7 | 0.130 |
Why?
|
| Mutant Proteins | 1 | 2017 | 104 | 0.130 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2017 | 8 | 0.130 |
Why?
|
| Gene Expression | 1 | 2020 | 831 | 0.130 |
Why?
|
| Neurokinin-1 Receptor Antagonists | 1 | 2017 | 23 | 0.130 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2018 | 197 | 0.130 |
Why?
|
| MicroRNAs | 1 | 2003 | 680 | 0.130 |
Why?
|
| Autophagy-Related Protein-1 Homolog | 1 | 2016 | 10 | 0.130 |
Why?
|
| Indoles | 1 | 2017 | 110 | 0.130 |
Why?
|
| Carotid Artery Diseases | 1 | 2017 | 66 | 0.130 |
Why?
|
| Neuroblastoma | 1 | 2017 | 52 | 0.130 |
Why?
|
| Morpholines | 1 | 2017 | 89 | 0.130 |
Why?
|
| Enzyme Activation | 4 | 2005 | 379 | 0.130 |
Why?
|
| Peptides | 2 | 2015 | 571 | 0.130 |
Why?
|
| Prodrugs | 1 | 2017 | 36 | 0.130 |
Why?
|
| DNA | 1 | 2021 | 829 | 0.130 |
Why?
|
| Cytochromes c | 2 | 2006 | 29 | 0.130 |
Why?
|
| Protein Domains | 1 | 2017 | 146 | 0.130 |
Why?
|
| Obesity | 2 | 2022 | 1223 | 0.120 |
Why?
|
| RNA Splicing | 1 | 2017 | 162 | 0.120 |
Why?
|
| Caspase Inhibitors | 2 | 2008 | 21 | 0.120 |
Why?
|
| Lysophosphatidylcholines | 1 | 2015 | 2 | 0.120 |
Why?
|
| Breast Neoplasms | 2 | 2015 | 1189 | 0.120 |
Why?
|
| Phosphatidylserines | 1 | 2015 | 13 | 0.120 |
Why?
|
| Chemokine CX3CL1 | 1 | 2015 | 8 | 0.120 |
Why?
|
| Sphingosine | 1 | 2015 | 20 | 0.120 |
Why?
|
| Caspase 8 | 1 | 2016 | 64 | 0.120 |
Why?
|
| Lysophospholipids | 1 | 2015 | 27 | 0.120 |
Why?
|
| In Situ Hybridization | 2 | 2014 | 216 | 0.120 |
Why?
|
| Epistasis, Genetic | 2 | 2006 | 42 | 0.120 |
Why?
|
| Patient Readmission | 1 | 2019 | 430 | 0.120 |
Why?
|
| Morphogenesis | 1 | 2015 | 109 | 0.120 |
Why?
|
| Kidney | 2 | 2016 | 441 | 0.120 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 215 | 0.120 |
Why?
|
| Stroke | 2 | 2022 | 1189 | 0.120 |
Why?
|
| Risk Factors | 6 | 2025 | 5324 | 0.120 |
Why?
|
| Genes, erbB-1 | 1 | 2014 | 1 | 0.110 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2016 | 129 | 0.110 |
Why?
|
| Aged | 9 | 2025 | 14335 | 0.110 |
Why?
|
| Immunoenzyme Techniques | 1 | 2014 | 107 | 0.110 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2008 | 324 | 0.110 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 1271 | 0.100 |
Why?
|
| Embryo, Nonmammalian | 2 | 2005 | 175 | 0.100 |
Why?
|
| Wnt Signaling Pathway | 1 | 2014 | 80 | 0.100 |
Why?
|
| Sweden | 3 | 2019 | 58 | 0.100 |
Why?
|
| Ecdysone | 1 | 2013 | 15 | 0.100 |
Why?
|
| Salivary Glands | 1 | 2013 | 46 | 0.100 |
Why?
|
| Predictive Value of Tests | 3 | 2025 | 1080 | 0.100 |
Why?
|
| Mitogens | 1 | 2012 | 10 | 0.100 |
Why?
|
| Mitosis | 1 | 2014 | 215 | 0.100 |
Why?
|
| MAP Kinase Kinase Kinases | 2 | 2003 | 82 | 0.100 |
Why?
|
| Middle Aged | 9 | 2025 | 17489 | 0.100 |
Why?
|
| Cells, Cultured | 2 | 2014 | 2140 | 0.090 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 735 | 0.090 |
Why?
|
| Prospective Studies | 4 | 2025 | 3272 | 0.090 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 431 | 0.090 |
Why?
|
| Up-Regulation | 1 | 2013 | 369 | 0.090 |
Why?
|
| Cytokines | 1 | 2015 | 926 | 0.090 |
Why?
|
| Retinoblastoma-Binding Protein 4 | 1 | 2011 | 2 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 662 | 0.090 |
Why?
|
| RNA, Messenger | 1 | 2017 | 1530 | 0.090 |
Why?
|
| Animals, Genetically Modified | 2 | 2011 | 288 | 0.090 |
Why?
|
| Ligands | 1 | 2012 | 414 | 0.090 |
Why?
|
| Biomarkers, Tumor | 1 | 2014 | 500 | 0.090 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2009 | 216 | 0.080 |
Why?
|
| Serrate-Jagged Proteins | 1 | 2010 | 6 | 0.080 |
Why?
|
| Jagged-1 Protein | 1 | 2010 | 8 | 0.080 |
Why?
|
| Pigmentation | 1 | 2010 | 24 | 0.080 |
Why?
|
| TRPA1 Cation Channel | 1 | 2010 | 3 | 0.080 |
Why?
|
| TRPC Cation Channels | 1 | 2010 | 11 | 0.080 |
Why?
|
| Prognosis | 3 | 2019 | 1738 | 0.080 |
Why?
|
| Body Patterning | 2 | 2011 | 82 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2009 | 53 | 0.080 |
Why?
|
| Receptors, Cell Surface | 1 | 2012 | 427 | 0.080 |
Why?
|
| Calcium-Binding Proteins | 1 | 2010 | 90 | 0.080 |
Why?
|
| Phosphorylation | 2 | 2002 | 933 | 0.080 |
Why?
|
| Protein Isoforms | 1 | 2010 | 197 | 0.080 |
Why?
|
| Ion Channels | 1 | 2010 | 89 | 0.080 |
Why?
|
| Cell Respiration | 2 | 2006 | 21 | 0.080 |
Why?
|
| Alternative Splicing | 1 | 2010 | 126 | 0.080 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2010 | 151 | 0.080 |
Why?
|
| Cell Line | 2 | 2011 | 2028 | 0.080 |
Why?
|
| Oogenesis | 1 | 2009 | 43 | 0.080 |
Why?
|
| Cohort Studies | 3 | 2022 | 2554 | 0.080 |
Why?
|
| Epitopes | 1 | 2009 | 289 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2010 | 488 | 0.070 |
Why?
|
| Wnt1 Protein | 1 | 2008 | 12 | 0.070 |
Why?
|
| Mutagenesis | 2 | 2006 | 132 | 0.070 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2008 | 107 | 0.070 |
Why?
|
| Conserved Sequence | 1 | 2007 | 174 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2007 | 130 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2009 | 336 | 0.060 |
Why?
|
| Apoptosomes | 1 | 2006 | 1 | 0.060 |
Why?
|
| Ethyl Methanesulfonate | 1 | 2006 | 3 | 0.060 |
Why?
|
| RNA Interference | 1 | 2010 | 618 | 0.060 |
Why?
|
| Cell Line, Tumor | 3 | 2017 | 1458 | 0.060 |
Why?
|
| Codon, Nonsense | 1 | 2006 | 58 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2006 | 361 | 0.060 |
Why?
|
| Genes, Reporter | 1 | 2006 | 255 | 0.060 |
Why?
|
| Spermatogenesis | 1 | 2005 | 72 | 0.060 |
Why?
|
| Risk Assessment | 2 | 2025 | 2065 | 0.060 |
Why?
|
| Eye Abnormalities | 1 | 2005 | 21 | 0.060 |
Why?
|
| Mutation, Missense | 1 | 2006 | 186 | 0.060 |
Why?
|
| Cell Count | 2 | 2002 | 130 | 0.060 |
Why?
|
| Ovary | 1 | 2005 | 100 | 0.060 |
Why?
|
| Sex Factors | 2 | 2018 | 971 | 0.060 |
Why?
|
| Flow Cytometry | 2 | 2017 | 659 | 0.060 |
Why?
|
| DNA Mutational Analysis | 1 | 2005 | 193 | 0.060 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 5432 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 932 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2003 | 57 | 0.050 |
Why?
|
| Cell Movement | 1 | 2005 | 451 | 0.050 |
Why?
|
| bcl-Associated Death Protein | 1 | 2002 | 10 | 0.050 |
Why?
|
| Spermatozoa | 1 | 2005 | 257 | 0.050 |
Why?
|
| Ceramides | 1 | 2002 | 25 | 0.050 |
Why?
|
| Growth Hormone | 1 | 2022 | 18 | 0.050 |
Why?
|
| Nucleic Acid Conformation | 1 | 2003 | 239 | 0.050 |
Why?
|
| Ligases | 1 | 2002 | 27 | 0.050 |
Why?
|
| Capillary Permeability | 1 | 2022 | 16 | 0.050 |
Why?
|
| Epinephrine | 1 | 2022 | 43 | 0.050 |
Why?
|
| Cell Division | 1 | 2003 | 447 | 0.050 |
Why?
|
| Epidermal Growth Factor | 1 | 2002 | 47 | 0.050 |
Why?
|
| Methylation | 2 | 2013 | 127 | 0.050 |
Why?
|
| Insect Proteins | 1 | 2002 | 79 | 0.050 |
Why?
|
| Norepinephrine | 1 | 2022 | 101 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2017 | 5630 | 0.040 |
Why?
|
| Autophagy-Related Proteins | 1 | 2021 | 16 | 0.040 |
Why?
|
| Autophagosomes | 1 | 2021 | 13 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2022 | 173 | 0.040 |
Why?
|
| Base Sequence | 1 | 2003 | 1322 | 0.040 |
Why?
|
| Biological Assay | 1 | 2021 | 58 | 0.040 |
Why?
|
| Time Factors | 2 | 2019 | 3752 | 0.040 |
Why?
|
| Life Style | 1 | 2022 | 310 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2022 | 183 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2020 | 146 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2021 | 369 | 0.040 |
Why?
|
| Weight Loss | 1 | 2022 | 271 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2021 | 384 | 0.040 |
Why?
|
| Lysosomes | 1 | 2021 | 167 | 0.040 |
Why?
|
| Adrenomedullin | 1 | 2019 | 5 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2021 | 433 | 0.040 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2019 | 13 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2002 | 610 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2017 | 2562 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2002 | 573 | 0.040 |
Why?
|
| Proteins | 1 | 2005 | 747 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 854 | 0.040 |
Why?
|
| Diagnostic Techniques, Endocrine | 1 | 2018 | 2 | 0.040 |
Why?
|
| Cause of Death | 1 | 2019 | 220 | 0.040 |
Why?
|
| Age Factors | 2 | 2018 | 1549 | 0.040 |
Why?
|
| Age of Onset | 1 | 2018 | 174 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2002 | 1003 | 0.030 |
Why?
|
| Adrenergic beta-1 Receptor Antagonists | 1 | 2017 | 7 | 0.030 |
Why?
|
| Metoprolol | 1 | 2017 | 15 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2003 | 918 | 0.030 |
Why?
|
| Geriatric Assessment | 1 | 2018 | 163 | 0.030 |
Why?
|
| E2F2 Transcription Factor | 1 | 2017 | 2 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2017 | 67 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 97 | 0.030 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2020 | 234 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2017 | 269 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 189 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2017 | 129 | 0.030 |
Why?
|
| Linear Models | 1 | 2017 | 408 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2016 | 32 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2016 | 45 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2016 | 99 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2016 | 126 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2019 | 511 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 459 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 449 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2016 | 190 | 0.030 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2016 | 81 | 0.030 |
Why?
|
| Exercise | 1 | 2022 | 939 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 233 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2017 | 734 | 0.030 |
Why?
|
| Reference Values | 1 | 2015 | 334 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2017 | 761 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 767 | 0.030 |
Why?
|
| Receptors, Steroid | 1 | 2013 | 26 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 727 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 2452 | 0.020 |
Why?
|
| Incidence | 1 | 2016 | 1369 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2014 | 765 | 0.020 |
Why?
|
| Genes, Homeobox | 1 | 2011 | 25 | 0.020 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 2011 | 31 | 0.020 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2011 | 32 | 0.020 |
Why?
|
| Diet | 1 | 2014 | 520 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2014 | 310 | 0.020 |
Why?
|
| Young Adult | 1 | 2020 | 4669 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 668 | 0.020 |
Why?
|
| United States | 1 | 2022 | 7782 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 2009 | 65 | 0.020 |
Why?
|
| Gene Knock-In Techniques | 1 | 2009 | 43 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2009 | 203 | 0.020 |
Why?
|
| Caspases, Effector | 1 | 2008 | 1 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2009 | 146 | 0.020 |
Why?
|
| Peptide Hydrolases | 1 | 2008 | 77 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2009 | 299 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2011 | 384 | 0.020 |
Why?
|
| Kinetics | 1 | 2008 | 759 | 0.020 |
Why?
|
| Pupa | 1 | 2006 | 17 | 0.020 |
Why?
|
| Spermatids | 1 | 2005 | 11 | 0.020 |
Why?
|
| Genes, Lethal | 1 | 2005 | 42 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2008 | 778 | 0.020 |
Why?
|
| Infertility, Male | 1 | 2005 | 56 | 0.010 |
Why?
|
| Adult | 1 | 2020 | 16722 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2002 | 109 | 0.010 |
Why?
|
| Neurons, Afferent | 1 | 2002 | 17 | 0.010 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2002 | 24 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2003 | 375 | 0.010 |
Why?
|
| Mitochondria | 1 | 2005 | 361 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 538 | 0.010 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2002 | 103 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2002 | 486 | 0.010 |
Why?
|